Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from Naturex SA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim relate...

Full description

Bibliographic Details
Main Author: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Format: Article
Language:English
Published: Wiley 2014-05-01
Series:EFSA Journal
Subjects:
Online Access:http://www.efsa.europa.eu/en/efsajournal/doc/3656.pdf
_version_ 1818728097974845440
author EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
author_facet EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
author_sort EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
collection DOAJ
description Following an application from Naturex SA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract. The food that is the subject of the claim is Pacran®. The Panel considers that the food, Pacran®, which is the subject of the claim is sufficiently characterised in relation to the claimed effect. The Panel considers that defence against bacterial pathogens in the lower urinary tract is a beneficial physiological effect. One human study from which conclusions could be drawn for the scientific substantiation of the claim showed no effect of Pacran® on defence against bacterial pathogens in the lower urinary tract. The Panel concludes that a cause and effect relationship has not been established between the consumption of Pacran® and defence against bacterial pathogens in the lower urinary tract.
first_indexed 2024-12-17T22:24:35Z
format Article
id doaj.art-8bc2a9938bff45669c6fffefe4508472
institution Directory Open Access Journal
issn 1831-4732
language English
last_indexed 2024-12-17T22:24:35Z
publishDate 2014-05-01
publisher Wiley
record_format Article
series EFSA Journal
spelling doaj.art-8bc2a9938bff45669c6fffefe45084722022-12-21T21:30:23ZengWileyEFSA Journal1831-47322014-05-0112510.2903/j.efsa.2014.3656EFSA Journal 2014;12(5):3656Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Following an application from Naturex SA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract. The food that is the subject of the claim is Pacran®. The Panel considers that the food, Pacran®, which is the subject of the claim is sufficiently characterised in relation to the claimed effect. The Panel considers that defence against bacterial pathogens in the lower urinary tract is a beneficial physiological effect. One human study from which conclusions could be drawn for the scientific substantiation of the claim showed no effect of Pacran® on defence against bacterial pathogens in the lower urinary tract. The Panel concludes that a cause and effect relationship has not been established between the consumption of Pacran® and defence against bacterial pathogens in the lower urinary tract.http://www.efsa.europa.eu/en/efsajournal/doc/3656.pdfPacran®proanthocyanidinscranberryVaccinium macrocarponurinary tracthealth claims
spellingShingle EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
EFSA Journal
Pacran®
proanthocyanidins
cranberry
Vaccinium macrocarpon
urinary tract
health claims
title Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_fullStr Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full_unstemmed Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_short Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_sort scientific opinion on the substantiation of a health claim related to pacran r and defence against bacterial pathogens in the lower urinary tract pursuant to article 13 5 of regulation ec no 1924 2006
topic Pacran®
proanthocyanidins
cranberry
Vaccinium macrocarpon
urinary tract
health claims
url http://www.efsa.europa.eu/en/efsajournal/doc/3656.pdf
work_keys_str_mv AT efsapanelondieteticproductsnutritionandallergiesnda scientificopiniononthesubstantiationofahealthclaimrelatedtopacrananddefenceagainstbacterialpathogensinthelowerurinarytractpursuanttoarticle135ofregulationecno19242006